Description

Levetiracetam Grindex Coated Tablets 250 mg. №30

Ingredients:

Levetiracetam is the active ingredient in each coated tablet. Other ingredients include lactose monohydrate, maize starch, talc, and magnesium stearate.

Dosage:

It is recommended to take 250 mg of Levetiracetam Grindex coated tablets orally twice a day. Follow your healthcare provider’s instructions for the best results.

Indications:

Levetiracetam Grindex coated tablets are indicated for the treatment of epilepsy in adults and children. It helps control seizures by stabilizing electrical activity in the brain.

Contraindications:

Avoid Levetiracetam Grindex coated tablets if you are allergic to levetiracetam or any other ingredients in the formulation. Consult your doctor before use, especially if you have kidney problems.

Directions:

Swallow the tablets whole with a glass of water. Do not crush or chew them. You can take them with or without food, but it is essential to maintain a consistent dosing schedule.

Scientific Evidence:

Studies have shown that Levetiracetam is effective in reducing seizure frequency and improving seizure control in patients with epilepsy. Research published in the Journal of Neurology demonstrated the drug’s efficacy and tolerability in both adults and children.

Additional Information:

Levetiracetam Grindex coated tablets should be stored at room temperature away from moisture and heat. Keep them out of reach of children. If you miss a dose, take it as soon as you remember, unless it is close to the next dose. In that case, skip the missed dose and continue with your regular dosing schedule.

It is important to attend regular check-ups with your healthcare provider while taking Levetiracetam to monitor its effectiveness and any potential side effects. Do not discontinue the medication abruptly without consulting your doctor.

Levetiracetam works by modulating neurotransmitter release, which helps to reduce abnormal electrical activity in the brain that leads to seizures. Its precise mechanism of action is not fully understood, but it is believed to involve binding to synaptic vesicle protein 2A (SV2A).

Compared to traditional antiepileptic drugs, Levetiracetam has shown comparable efficacy with a more favorable side effect profile. It is well-tolerated and has a low potential for drug interactions, making it a preferred choice for many patients with epilepsy.